. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/pharmacologyDNA Topoisomerases, Type I/metabolismDNA Topoisomerases, Type II/metabolismHumansNeoplasms/drug therapy
Substances: See more » Antineoplastic AgentsDNA Topoisomerases, Type IDNA Topoisomerases, Type II
Year: 1988 PMID: 2893923
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321